Cilastatin enantiomer | CAS 107873-05-2 - Request Quote
Cilastatin enantiomer
| SZ CAT No: | SZ-C073014 |
| CAS No | 107873-05-2 |
| Mol.F. | C16H26N2O5S |
| Mol.Wt. | 358.5 |
| Inv. Status | Under QC Approval |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Cilastatin enantiomer is chemically (Z)-7-(((S)-2-Amino-2-carboxyethyl)thio)-2-((S)-2,2-dimethylcyclopropane-1-carboxamido)hept-2-enoic acid. Cilastatin enantiomer is supplied with detailed characterization data compliant with regulatory guideline. Cilastatin enantiomer can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Cilastatin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 107873-05-2
Purchase 107873-05-2
Order 107873-05-2
Enquire 107873-05-2
price of 107873-05-2
107873-05-2 Supplier
107873-05-2 Manufacturer
107873-05-2 Exporter
buy high quality Cilastatin enantiomer
Purchase Cilastatin enantiomer
Cilastatin enantiomer suppliers
Cilastatin enantiomer manufacturers
Cilastatin enantiomer price
Order Cilastatin enantiomer
Enquire Cilastatin enantiomer
Cilastatin enantiomer cost
Cilastatin enantiomer Supplier
Cilastatin enantiomer Distributor
Cilastatin enantiomer for Method Validation
Cilastatin Reference Standard
Cilastatin enantiomer for ANDA Filing
Cilastatin enantiomer for Forced Degradation Studies
Cilastatin enantiomer Identification Standards
Cilastatin enantiomer for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.